Geode Capital Management’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $562K | Buy |
|
|||||
|
2025
Q1 | $276K | Buy |
|
|||||
|
2024
Q4 | $163K | Sell |
|
|||||
|
2024
Q3 | $131K | Buy |
|
|||||
|
2024
Q2 | $160K | Buy |
|
|||||
|
2024
Q1 | $198K | Buy |
|
|||||
|
2023
Q4 | $190K | Hold |
|
|||||
|
2023
Q3 | $107K | Buy |
|
|||||
|
2023
Q2 | $183K | Hold |
|
|||||
|
2023
Q1 | $250K | Hold |
|
|||||
|
2022
Q4 | $420K | Buy |
|
|||||
|
2022
Q3 | $237K | Buy |
|
|||||
|
2022
Q2 | $185K | Buy |
|
|||||
|
2022
Q1 | $719K | Buy |
|
|||||
|
2021
Q4 | $1.01M | Buy |
|
|||||
|
2021
Q3 | $424K | Buy |
|
|||||
|
2021
Q2 | $400K | Buy |
|